Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,886 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,267
Ph III recruiting: 131
Growth YoY: +4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,374)

clinicaltrialsPublishedShowing 4,001–4,050 of 4,268 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00366275	Immunochemotherapy, in Vivo Purging, PBSC Mobilization and Autotransplant in Relapsed or Refractory Follicular Lymphoma	completed	Phase 2	64	Fondazione IRCCS Policlinico San Matteo di PaviaOTHER	1	Oct 31, 2012	clinicaltrials
NCT00742495	Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma.(BCX1777-108)	terminated	Phase 1 / Phase 2	2	Mundipharma Research LimitedINDUSTRY